CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, confirms that, in accordance with the provisions of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback